Webinar: Pellets from fluid bed processes – a smart concept for high(er) potent drug processing
Manufacturing tablets is frequently a multi-step process: weighing, granulation, milling, blending, compression, coating. The efforts to provide a safe work environment for the production staff are considerably reduced when a technology platform like pellets is applied for high potent APIs.
Contact with the potent API can be limited to the weighing step. Less manufacturing steps also means: reduced risk for cross contamination.
OEL calculations for the drug products to be produced is demonstrated. Cleaning of equipment considering GMP acceptance criteria is discussed.
Watch the full webinar for free here
Q1: Cetirizine hydrochloride being a crystalline API. So when loaded there may be a possibility of recrystallization of the drug, leading to irregular shaped pellets, leading to non-uniformity when considered for next coating. How to resolve such issues?
Q2: How to clean the dust from the exhaust air?
Q3: Is it possible to coat tablets ranging from 6mm to 10mm in size using wurster coater and which base plate combination one has to use?
Speaker: Dr. Norbert Pöllinger
Norbert Poellinger is heading the Technology Development unit. Until 2018, he was responsible for Development and Manufacturing Services Group at Glatt Pharmaceutical Services which included Pharmaceutical Development, Manufacturing, Quality Control, Quality Assurance and Plant Engineering. He studied pharmaceutical sciences at the University of Erlangen, Germany and received a PhD degree in Pharmaceutical Technology. Currently, the recently formed Glatt Pharmaceutical Services GmbH & Co.KG focuses on controlled release and taste masked multiparticulates including minitablets and tablets. Drug products for the paediatric and geriatric population are of particular interest. Logistic services have become a new service opportunity of Glatt